Search

    Language Settings
    Select Website Language

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    BijnorNews
    Bijnor news

    Delhi High Court Restrains Intas From Using Cancer Drug Brand 'BEVATAS'

    2 days ago

    Sun Pharma argued that the mark was deceptively similar to "BEVETEX" and posed serious public health risks due to the possibility of confusion between oncology drugs.
    Click here to Read More
    Previous Article
    Sun Pharma, Bharti Airtel, NTPC: HSBC's Herald van der Linde Maps Asia's Next Big Bets
    Next Article
    Paras Defence And The Rs 27,000 Crore Spy Satellite Project: Space Optics Are The New Margin Engine — Here's Why

    Related Business Updates:

    Are you sure? You want to delete this comment..! Remove Cancel

    Comments (0)

      Leave a comment